| Tracy Lynn Haynes, MA,LCPC | |
|
2615 Edwards St, Alton, IL 62002-3915 | |
| (618) 462-2331 | |
| (618) 462-2504 |
| Full Name | Tracy Lynn Haynes |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 2615 Edwards St, Alton, Illinois |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235597147 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | 180.010118 (Illinois) | Primary |
| Entity Name | Centerstone Of Illinois Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053455667 PECOS PAC ID: 2961545173 Enrollment ID: O20100209000763 |
News Archive
A clinical trial of 75 patients hospitalized with acute decompensated heart failure suggests that aggressive fluid and sodium restriction has no effect on weight loss or clinical stability at three days but was associated with an increase in perceived thirst, according to a study published Online First by JAMA Internal Medicine, a JAMA Network publication.
NovaBay Pharmaceuticals, Inc., a clinical stage specialty pharmaceutical company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, today reported full-year and fourth quarter financial results for 2009. The company also highlighted recent progress of its proprietary and partnered development programs.
Verisk Health, Inc. today announced that Med-Vision, LLC helped clients reduce healthcare costs by 10 to 12 percent with Verisk Health's Explorer solution. Verisk Health is a global leader in identifying, analyzing, and predicting healthcare risk. Med-Vision is a leading medical consulting company.
Patients with triple negative breast cancer that also have mutations in the BRCA gene appear to have a lower risk of recurrence, compared to those with the same disease without the deleterious genetic mutation, according to researchers at The University of Texas MD Anderson Cancer Center.
PharmAbcine, a specialized biotech company focused on the development of fully-human monoclonal antibodies for the treatment of cancer and inflammatory diseases, announced that is has received $6 million USD in a Series A financing. OrbiMed's Caduceus Asia Partners and Novartis Korea Venture Fund co-led the round, with additional participation from an international syndicate including Green Cross, Tong Yang and Saehan Venture Fund.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Tracy Lynn Haynes, MA,LCPC 902 W Main St, West Frankfort, IL 62896-2210 Ph: (618) 937-6483 | Tracy Lynn Haynes, MA,LCPC 2615 Edwards St, Alton, IL 62002-3915 Ph: (618) 462-2331 |
News Archive
A clinical trial of 75 patients hospitalized with acute decompensated heart failure suggests that aggressive fluid and sodium restriction has no effect on weight loss or clinical stability at three days but was associated with an increase in perceived thirst, according to a study published Online First by JAMA Internal Medicine, a JAMA Network publication.
NovaBay Pharmaceuticals, Inc., a clinical stage specialty pharmaceutical company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, today reported full-year and fourth quarter financial results for 2009. The company also highlighted recent progress of its proprietary and partnered development programs.
Verisk Health, Inc. today announced that Med-Vision, LLC helped clients reduce healthcare costs by 10 to 12 percent with Verisk Health's Explorer solution. Verisk Health is a global leader in identifying, analyzing, and predicting healthcare risk. Med-Vision is a leading medical consulting company.
Patients with triple negative breast cancer that also have mutations in the BRCA gene appear to have a lower risk of recurrence, compared to those with the same disease without the deleterious genetic mutation, according to researchers at The University of Texas MD Anderson Cancer Center.
PharmAbcine, a specialized biotech company focused on the development of fully-human monoclonal antibodies for the treatment of cancer and inflammatory diseases, announced that is has received $6 million USD in a Series A financing. OrbiMed's Caduceus Asia Partners and Novartis Korea Venture Fund co-led the round, with additional participation from an international syndicate including Green Cross, Tong Yang and Saehan Venture Fund.
› Verified 1 days ago
Elissha Lenhardt, Counselor Medicare: Not Enrolled in Medicare Practice Location: 2615 Edwards St, Alton, IL 62002 Phone: 618-462-2331 Fax: 618-462-2504 | |
Jennifer Tapen, Counselor Medicare: Not Enrolled in Medicare Practice Location: 2615 Edwards St, Alton, IL 62002 Phone: 618-462-2331 Fax: 618-462-2504 | |
Emily Pembrook, Counselor Medicare: Not Enrolled in Medicare Practice Location: 2615 Edwards St, Alton, IL 62002 Phone: 618-462-2331 Fax: 618-462-2504 | |
Joshua Lupardus, Counselor Medicare: Not Enrolled in Medicare Practice Location: 2615 Edwards St, Alton, IL 62002 Phone: 618-462-2331 Fax: 618-462-7160 | |
Lauren Lumpkins, Counselor Medicare: Not Enrolled in Medicare Practice Location: 2615 Edwards St, Alton, IL 62002 Phone: 618-462-2331 Fax: 618-462-2504 | |
Erin Loebner, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 2615 Edwards St, Alton, IL 62002 Phone: 618-462-2331 Fax: 618-462-2504 | |
Ms. Linda K Moffatt, LCPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 611 W Delmar Ave, Alton, IL 62002 Phone: 618-791-8006 Fax: 618-243-6558 |